Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapyL B J van Iersel, M Koopman, C J H van de Velde, et al.
Breast Cancer Research and Treatment|July 12, 2013
CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trialV O Dezentjé, R H N van Schaik, J M Vletter-Bogaartz, et al.
Breast (Edinburgh, Scotland)|November 29, 2015
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)A Charehbili, N A T Hamdy, V T H B M Smit, et al.
The British Journal of Surgery|April 16, 2010
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countriesJ G H van Nes, C Seynaeve, S Jones, et al.
Breast Cancer Research and Treatment|March 15, 2019
Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapyA F de Groot, E J Blok, A Charehbili, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2012
Relevant impact of central pathology review on nodal classification in individual breast cancer patientsJ H M J Vestjens, M J Pepels, M de Boer, et al.
Breast Cancer Research and Treatment|May 18, 2011
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapyR I Lalisang, F L G Erdkamp, C J Rodenburg, et al.
Breast Cancer Research and Treatment|January 6, 2015
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)S de Groot, L G M Janssen, A Charehbili, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)A Charehbili, S van de Ven, V T H B M Smit, et al.
Pageof 8